[Various internal medicine aspects of the future therapy for diabetic retinopathy].
D000328:Adult; D000970:Antineoplastic Agents / Q000008:administration & dosage; D001379:Azathioprine / Q000008:administration & dosage / Q000009:adverse effects; D002994:Clofibrate / Q000008:administration & dosage; D003930:Diabetic Retinopathy / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy* / Q000517:prevention & control; D005260:Female; D013006:Growth Hormone / Q000008:administration & dosage; D006801:Humans; D006949:Hyperlipidemias / Q000150:complications / Q000188:drug therapy; D000960:Hypolipidemic Agents / Q000008:administration & dosage*; D008297:Male; D008875:Middle Aged; D009281:Naphthalenes / Q000008:administration & dosage; D010636:Phenols / Q000008:administration & dosage; D010919:Placebos; D011422:Propionates / Q000008:administration & dosage
D000970:Antineoplastic Agents; D000960:Hypolipidemic Agents; D009281:Naphthalenes; D010636:Phenols; D010919:Placebos; D011422:Propionates; D013006:Growth Hormone; D002994:Clofibrate; D001379:Azathioprine
Einige internistische Aspekte der zukünftigen Therapie der diabetischen Retinopathie.